Jadis 13.5 mg (Levonorgestrel)

Adult dosage

This medication is inserted into the uterine cavity and is effective for three years after insertion. It should be inserted into the uterus within seven days of the start of menstruation and can be replaced with a new one at any time during the menstrual cycle. It can be inserted immediately if a miscarriage occurs within the first three months of pregnancy. If inserted postpartum, it should be done after waiting for the uterus to return to its original state, and after six weeks postpartum. This medication should only be inserted by medical professionals with experience in inserting intrauterine systems or training.

This medication should not be used in women who are pregnant or suspect they might be pregnant. It should also not be used if there is a high risk of pelvic infection or uterine infection, or if there is cervicitis or vaginitis present. Women who have experienced endometritis or infectious abortion after childbirth, as well as those with certain cancers such as cervical tumors, uterine cancer, or breast cancer, should avoid using this medication. Individuals allergic to any of the ingredients of this medication should also refrain from using it. This medication should be used with caution after consulting a specialist, and if symptoms of cardiovascular diseases such as severe headache, migraine, high blood pressure, jaundice, or stroke occur, immediate consultation with medical personnel should take place. Special caution is necessary for those with congenital heart disease or valvular heart disease. While using this medication, menstrual bleeding patterns may change, with possible amenorrhea or irregular bleeding occurring. If bleeding is heavy or persists, it must be reported to medical personnel. Before using this medication, a pelvic examination and confirmation of uterine position are required, and it should only be used after treating any infections. Pain, bleeding, or fainting may occur during the insertion process, so medical personnel's instructions should be followed. This medication can interact with other drugs, so it is essential to inform medical personnel about any other medications being taken. Particularly, certain antibiotics, anticonvulsants, and antifungals can have an effect. This medication should not be used during pregnancy, and if pregnancy is confirmed, immediate removal is recommended. Breastfeeding women can use it after six weeks postpartum, and it does not significantly affect breastfeeding. This medication is recommended for women aged 18 and older, and is not suitable for postmenopausal women or children. Products with damaged or opened sterilized packaging should not be used, and it should only be used once. Expired products should absolutely not be used.

Serious side effects

Hives, angioedema (severe swelling), rash, hypersensitivity reactions, hypersensitivity reactions including angioedema, uterine perforation, sepsis (including group A streptococcus), serious arterial diseases (stroke, myocardial infarction), jaundice, very severe headache, migraine with local migraine, transient ischemic attacks, increased blood pressure, increased incidence of ectopic pregnancy, pelvic infections, endometritis, lower abdominal pain associated with ectopic pregnancy, difficulty breathing, vasovagal reactions.

Mild side effects

Changes in menstrual bleeding (amenorrhea, rare bleeding, frequent bleeding, irregular bleeding, persistent bleeding), depression/depressive symptoms, headache, migraine, abdominal/pelvic pain, nausea, acne/seborrhea, alopecia, hirsutism, petechiae, oligomenorrhea, ovarian cysts, vulvovaginitis, upper genital tract infections, dysmenorrhea, breast pain/discomfort, expulsion of the intrauterine device, genital secretions, pain, and bleeding during insertion and removal, dizziness and fainting related to insertion.

This medication should be stored in a place that is not humid or exposed to direct sunlight, without opening the packaging. The appropriate storage temperature is between 1 to 30 degrees Celsius room temperature. Storing it this way will maintain the medication's efficacy and safety.

Appearance

This is an intrauterine system with a drug storage device that is white or pale yellow, wrapped in a translucent membrane and attached to the vertical portion of a T-shaped body. There is a ring at the end of the vertical part of the white T-shaped body, and at the other end, there are two.

Package unit

1 set